The Clinical Core is organized to provide the clinical samples for all 4 projects. The core will have 4functions: 1) to recruit and amange patients for the 3 protocols supporting the 4 projects, 2) to collect,process and catalogue all tissues (blood, lymph node, and GALT), 3) to assist the Administrative Core withtissue shipping and management of regulatory issues related to protocol administration, and 4) to maintainall patient and clinical laboratory records in a case report form and enter data into the established data base.Patients will be followed in the NIH funded General Clinical Research Center where all blood will be drawnand patients will receive required pre and post operative care. Tissues will receive initial processing throughthe clinical core and appropriate samples will be packed and shipped to off-site investigators. In addition, allclinical information (status, medications, clinical laboratory measures like CD4 and HIV viral load) will bemaintained in a patient chart and entered into a central database by the nurse manager. Over the course ofthese projects we will recruit 70 individuals into 3 protocols that require lymph node and colon biopsy. Wepresent data to show this goal is within the scope of recent accomplishments by our group. Protocol A willsupport Hypothesis 1 and distribute tissues to investigators in Projects 1, 2, and 4. Protocol B will supportHypothesis 2 and will distribute tissues to investigators in all 4 projects, and Protocol C will supportHypothesis 3 and distribute tissues to investigators in Projects 1, 2, and 4.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
1P01AI074340-01A2
Application #
7577049
Study Section
Special Emphasis Panel (ZAI1-CCH-A (M1))
Project Start
2008-09-30
Project End
2013-08-31
Budget Start
2008-09-30
Budget End
2009-08-31
Support Year
1
Fiscal Year
2008
Total Cost
$374,333
Indirect Cost
Name
University of Minnesota Twin Cities
Department
Type
DUNS #
555917996
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Kityo, Cissy; Makamdop, Krystelle Nganou; Rothenberger, Meghan et al. (2018) Lymphoid tissue fibrosis is associated with impaired vaccine responses. J Clin Invest 128:2763-2773
Estes, Jacob D; Kityo, Cissy; Ssali, Francis et al. (2017) Defining total-body AIDS-virus burden with implications for curative strategies. Nat Med 23:1271-1276
Cory, Theodore J; He, Hui; Winchester, Lee C et al. (2016) Alterations in P-Glycoprotein Expression and Function Between Macrophage Subsets. Pharm Res 33:2713-21
Lorenzo-Redondo, Ramon; Fryer, Helen R; Bedford, Trevor et al. (2016) Persistent HIV-1 replication maintains the tissue reservoir during therapy. Nature 530:51-56
Sanchez, Joyce L; Hunt, Peter W; Reilly, Cavan S et al. (2015) Lymphoid fibrosis occurs in long-term nonprogressors and persists with antiretroviral therapy but may be reversible with curative interventions. J Infect Dis 211:1068-75
Cory, Theodore J; Winchester, Lee C; Robbins, Brian L et al. (2015) A rapid spin through oil results in higher cell-associated concentrations of antiretrovirals compared with conventional cell washing. Bioanalysis 7:1447-55
Winchester, Lee C; Podany, Anthony T; Baldwin, Joshua S et al. (2015) Determination of the rifamycin antibiotics rifabutin, rifampin, rifapentine and their major metabolites in human plasma via simultaneous extraction coupled with LC/MS/MS. J Pharm Biomed Anal 104:55-61
Mitchell, Caroline; Roemer, Emily; Nkwopara, Evangelyn et al. (2014) Correlation between plasma, intracellular, and cervical tissue levels of raltegravir at steady-state dosing in healthy women. Antimicrob Agents Chemother 58:3360-5
Fletcher, Courtney V; Staskus, Kathryn; Wietgrefe, Stephen W et al. (2014) Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues. Proc Natl Acad Sci U S A 111:2307-12
Misemer, Benjamin S; Skubitz, Amy P N; Carlos Manivel, J et al. (2014) Expression of FAP, ADAM12, WISP1, and SOX11 is heterogeneous in aggressive fibromatosis and spatially relates to the histologic features of tumor activity. Cancer Med 3:81-90

Showing the most recent 10 out of 30 publications